Avalo Therapeutics (AVTX) Gross Profit (2017 - 2024)
Avalo Therapeutics (AVTX) posted Gross Profit of -$465,000 for Q3 2024, compared with -$11,000 a year earlier.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Gross Profit (2017 - 2024) Analysis & Trends
For the trailing twelve months through Sep 30, 2024, Gross Profit at Avalo Therapeutics was -$96,000; for FY2023, it came in at $640,000, down 95.6% from FY2022.
- Annual Gross Profit shows a five-year compound annual growth rate of -29.9% (FY2018 to FY2023).
- In prior years, Avalo Therapeutics' Gross Profit was $14.62 million in FY2022 (+274.1%), $3.91 million in FY2021 (-38.9%), $6.4 million in FY2020 (+3.5%) and $6.18 million in FY2019 (+64.1%).
- The Q3 2024 figure stands as the lowest quarterly Gross Profit since Q2 2022.
- The strongest year-over-year quarter for Gross Profit in the past five years was Q4 2023, with growth of 187.0%; the weakest was Q1 2021, with a decline of 85.3%.
- According to Business Quant data, Gross Profit for the three prior quarters was -$343,000 (Q2 2024), -$80,000 (Q1 2024) and $792,000 (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | Avalo Therapeutics | 302.16 Mn | -390.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -465,000.00 |
| Jun 30, 2024 | -343,000.00 |
| Mar 31, 2024 | -80,000.00 |
| Dec 31, 2023 | 792,000.00 |
| Sep 30, 2023 | -11,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Mar 31, 2023 | -76,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Sep 30, 2022 | 14.42 Mn |
| Jun 30, 2022 | -534,000.00 |
| Mar 31, 2022 | 453,000.00 |
| Dec 31, 2021 | -205,000.00 |
| Sep 30, 2021 | 442,000.00 |
| Jun 30, 2021 | 3.27 Mn |
| Mar 31, 2021 | 396,000.00 |
| Dec 31, 2020 | 1.42 Mn |
| Sep 30, 2020 | 1.03 Mn |
| Jun 30, 2020 | 1.26 Mn |
| Mar 31, 2020 | 2.69 Mn |
| Dec 31, 2019 | 3.26 Mn |
API Access
Avalo Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();